3rin: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
[[ | ==p38 kinase crystal structure in complex with small molecule inhibitor== | ||
<StructureSection load='3rin' size='340' side='right' caption='[[3rin]], [[Resolution|resolution]] 2.20Å' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>[[3rin]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3RIN OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3RIN FirstGlance]. <br> | |||
</td></tr><tr><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=I2O:N-CYCLOPROPYL-4-METHYL-3-(2-OXO-1,2-DIHYDROSPIRO[CYCLOPENTANE-1,3-INDOL]-6-YL)BENZAMIDE'>I2O</scene><br> | |||
<tr><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">CSBP, CSBP1, CSBP2, CSPB1, MAPK14, MXI2 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens])</td></tr> | |||
<tr><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Mitogen-activated_protein_kinase Mitogen-activated protein kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.11.24 2.7.11.24] </span></td></tr> | |||
<tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3rin FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3rin OCA], [http://www.rcsb.org/pdb/explore.do?structureId=3rin RCSB], [http://www.ebi.ac.uk/pdbsum/3rin PDBsum]</span></td></tr> | |||
<table> | |||
<div style="background-color:#fffaf0;"> | |||
== Publication Abstract from PubMed == | |||
The use of structure-based design and molecular modeling led to the discovery of indolin-2-one derivatives as potent and selective p38alpha inhibitors. The predicted binding mode was confirmed by X-ray crystallography. | |||
Indolin-2-one p38alpha inhibitors I: design, profiling and crystallographic binding mode.,Eastwood P, Gonzalez J, Gomez E, Vidal B, Caturla F, Roca R, Balague C, Orellana A, Dominguez M Bioorg Med Chem Lett. 2011 Jul 15;21(14):4130-3. Epub 2011 Jun 6. PMID:21696951<ref>PMID:21696951</ref> | |||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |||
</div> | |||
==See Also== | |||
*[[Mitogen-activated protein kinase|Mitogen-activated protein kinase]] | |||
== References == | |||
<references/> | |||
__TOC__ | |||
</StructureSection> | |||
== | |||
[[ | |||
== | |||
< | |||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Mitogen-activated protein kinase]] | [[Category: Mitogen-activated protein kinase]] |